Whistleblower Exposes 3 Big Issues in Pfizer’s ‘Covid’ fake vaccine Clinical Trials

On Nov. 2, 2021 British Medical Journal (BMJ) published an article that revealed three big issues in Pfizer’s vaccine trial based on interview with a whistleblower.

The whistle blower, Brook Jackson, was a regional director of one of Pfizer’s vaccine trial companies, Ventavia Research Group in Texas.

Beginning the fall of 2020, there were 153 institutes, including Ventavia, that assisted Pfizer’s vaccine clinical trial. Per Ventavia’s website, the company is the largest private clinical research company in Texas. Jackson found out the management of the clinical trial in the company was not organized. She reported this to the administrative level of the company, but received no response from the company. Then she reported this to the FDA.

However, after she emailed the FDA, she was fired that same afternoon. Jackson said this was the first time she was fired from her job in her 20-year career.

Finally, she contacted the international well-known journal–BMJ. She exposed 3 major issues she observed in Ventavia for Pfizer’s vaccine clinical trial.

1. Falsifying the data
2. Early unblinding of the trial, affecting the accuracy of the results
3. Very slow to respond to adverse events, and not paying attention to the safety of participants

We spoke with Dr. Sean Lin, phD, former toxicology lab director of Walter Reed Military Medical Center to discuss these issues. The interview below has been edited for brevity and clarity.

Read More: Whistleblower Exposes 3 Big Issues in Pfizer’s COVID Vaccine Clinical Trials